Science Explorer Interactive view Map
Nonprofit · Barcelona · Spain

Fundación Josep Carreras Contra la Leucemia

fcarreras.org/enROR OpenAlex
Research works
62
▲ 8% vs 2013–17
Citations
628
10.2 per fractional work
Top-10% rate
16.3%
record average 16.5%
Open access
51%
world 28%

Not ranked overall: Fundación Josep Carreras Contra la Leucemia is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.44× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 5.65× its world share, 1 worksImmunology and Micro…Neuroscience: 0.23× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 7.23× its world share, 1 worksPharmacology, Toxico…Computer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.05× its world share, 0 worksEngineeringMedicine: 3.75× its world share, 16 worksMedicineArts and Humanities: 0.63× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.04× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.14× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.21× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.2×. Every wedge is a field page.

Which keywords describe research at Fundación Josep Carreras Contra la Leucemia?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Mesenchymal Stem Cells, Rituximab, Bone Marrow Niche and Graft-versus-Host Disease.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Prognostic Factors4▲ 45×5 topics
  2. Hematopoietic Stem Cells4▲ 186×3 topics
  3. AML2▲ 199×1 topic
  4. Acute Myeloid Leukemia2▲ 199×1 topic
  5. Mesenchymal Stem Cells2▲ 68×2 topics
  6. Rituximab2▲ 45×2 topics
  7. Bone Marrow Niche1▲ 270×1 topic
  8. Graft-versus-Host Disease1▲ 270×1 topic
  9. Genetic Variation1▲ 25×3 topics
  10. Minimal Residual Disease1▲ 81×2 topics
  11. Acute Lymphoblastic Leukemia1▲ 145×1 topic
  12. Cancer1▲ 3.8×11 topics
  13. Childhood Cancer1▲ 145×1 topic
  14. Inflammation1▲ 2.5×11 topics
  15. Lymphoma1▲ 30×3 topics
  16. Therapeutic Targets1▲ 32×3 topics
  17. Chronic Lymphocytic Leukemia1▲ 102×1 topic
  18. Genomic Aberrations1▲ 102×1 topic

Which research topics does Fundación Josep Carreras Contra la Leucemia publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Acute Lymphoblastic Leukemia research and Chronic Lymphocytic Leukemia Research.

Acute Myeloid Leukemia R…2Acute Myeloid Leukemia Research: 2 fractional worksHematopoietic Stem Cell Transplantation: 1 fractional worksAcute Lymphoblastic Leuk…1Acute Lymphoblastic Leukemia research: 1 fractional worksChronic Lymphocytic Leuk…1Chronic Lymphocytic Leukemia Research: 1 fractional worksMyeloproliferative Neoplasms: Diagnosis and Treatment: 1 fractional worksChronic Myeloid Leukemia Treatments: 1 fractional worksNutrition, Genetics, and…1Nutrition, Genetics, and Disease: 1 fractional worksCAR-T cell therapy research: 1 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksTransplantation: Methods and Outcomes: 0 fractional works
HematologyPublic Health, Environmental and Occupational HealthGeneticsOncology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Acute Myeloid Leukemia Research Hematology 2 works
  2. 2 Hematopoietic Stem Cell Transplantation Hematology 1 works
  3. 3 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 1 works
  4. 4 Chronic Lymphocytic Leukemia Research Genetics 1 works
  5. 5 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 1 works
  6. 6 Chronic Myeloid Leukemia Treatments Hematology 1 works
  7. 7 Nutrition, Genetics, and Disease Genetics 1 works
  8. 8 CAR-T cell therapy research Oncology 1 works
  9. 9 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  10. 10 Transplantation: Methods and Outcomes Surgery 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.1%not open48.9%

World: 28% of research is openly available.

with international co-authors27.4%domestic only72.6%

World: 19% is written across borders.

How has Fundación Josep Carreras Contra la Leucemia's research output changed?

Output in 2018–2022 was 8% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Barcelona

All research institutions in Barcelona

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.